Automotive Valve Tappet
Automotive Valve Tappet market is segmented by Type and by Application. Players, stakeholders, an ... Read More
Global Risperidone Market Insights and Forecast to 2031
1 Study Coverage
1.1 Risperidone Product Introduction
1.2 Market by Type
1.2.1 Global Risperidone Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Oral
1.2.3 Injectable
1.3 Market by Application
1.3.1 Global Risperidone Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Schizophrenia
1.3.3 Bipolar Disorder
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Risperidone Sales Estimates and Forecasts 2017-2028
2.2 Global Risperidone Revenue Estimates and Forecasts 2017-2028
2.3 Global Risperidone Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Risperidone Sales by Region
2.4.1 Global Risperidone Sales by Region (2017-2022)
2.4.2 Global Sales Risperidone by Region (2023-2028)
2.5 Global Risperidone Revenue by Region
2.5.1 Global Risperidone Revenue by Region (2017-2022)
2.5.2 Global Risperidone Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Risperidone Sales by Manufacturers
3.1.1 Global Top Risperidone Manufacturers by Sales (2017-2022)
3.1.2 Global Risperidone Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Risperidone in 2021
3.2 Global Risperidone Revenue by Manufacturers
3.2.1 Global Risperidone Revenue by Manufacturers (2017-2022)
3.2.2 Global Risperidone Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Risperidone Revenue in 2021
3.3 Global Risperidone Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Risperidone Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Risperidone Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Risperidone Sales by Type
4.1.1 Global Risperidone Historical Sales by Type (2017-2022)
4.1.2 Global Risperidone Forecasted Sales by Type (2023-2028)
4.1.3 Global Risperidone Sales Market Share by Type (2017-2028)
4.2 Global Risperidone Revenue by Type
4.2.1 Global Risperidone Historical Revenue by Type (2017-2022)
4.2.2 Global Risperidone Forecasted Revenue by Type (2023-2028)
4.2.3 Global Risperidone Revenue Market Share by Type (2017-2028)
4.3 Global Risperidone Price by Type
4.3.1 Global Risperidone Price by Type (2017-2022)
4.3.2 Global Risperidone Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Risperidone Sales by Application
5.1.1 Global Risperidone Historical Sales by Application (2017-2022)
5.1.2 Global Risperidone Forecasted Sales by Application (2023-2028)
5.1.3 Global Risperidone Sales Market Share by Application (2017-2028)
5.2 Global Risperidone Revenue by Application
5.2.1 Global Risperidone Historical Revenue by Application (2017-2022)
5.2.2 Global Risperidone Forecasted Revenue by Application (2023-2028)
5.2.3 Global Risperidone Revenue Market Share by Application (2017-2028)
5.3 Global Risperidone Price by Application
5.3.1 Global Risperidone Price by Application (2017-2022)
5.3.2 Global Risperidone Price Forecast by Application (2023-2028)
6 North America
6.1 North America Risperidone Market Size by Type
6.1.1 North America Risperidone Sales by Type (2017-2028)
6.1.2 North America Risperidone Revenue by Type (2017-2028)
6.2 North America Risperidone Market Size by Application
6.2.1 North America Risperidone Sales by Application (2017-2028)
6.2.2 North America Risperidone Revenue by Application (2017-2028)
6.3 North America Risperidone Market Size by Country
6.3.1 North America Risperidone Sales by Country (2017-2028)
6.3.2 North America Risperidone Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Risperidone Market Size by Type
7.1.1 Europe Risperidone Sales by Type (2017-2028)
7.1.2 Europe Risperidone Revenue by Type (2017-2028)
7.2 Europe Risperidone Market Size by Application
7.2.1 Europe Risperidone Sales by Application (2017-2028)
7.2.2 Europe Risperidone Revenue by Application (2017-2028)
7.3 Europe Risperidone Market Size by Country
7.3.1 Europe Risperidone Sales by Country (2017-2028)
7.3.2 Europe Risperidone Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Risperidone Market Size by Type
8.1.1 Asia Pacific Risperidone Sales by Type (2017-2028)
8.1.2 Asia Pacific Risperidone Revenue by Type (2017-2028)
8.2 Asia Pacific Risperidone Market Size by Application
8.2.1 Asia Pacific Risperidone Sales by Application (2017-2028)
8.2.2 Asia Pacific Risperidone Revenue by Application (2017-2028)
8.3 Asia Pacific Risperidone Market Size by Region
8.3.1 Asia Pacific Risperidone Sales by Region (2017-2028)
8.3.2 Asia Pacific Risperidone Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Risperidone Market Size by Type
9.1.1 Latin America Risperidone Sales by Type (2017-2028)
9.1.2 Latin America Risperidone Revenue by Type (2017-2028)
9.2 Latin America Risperidone Market Size by Application
9.2.1 Latin America Risperidone Sales by Application (2017-2028)
9.2.2 Latin America Risperidone Revenue by Application (2017-2028)
9.3 Latin America Risperidone Market Size by Country
9.3.1 Latin America Risperidone Sales by Country (2017-2028)
9.3.2 Latin America Risperidone Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Risperidone Market Size by Type
10.1.1 Middle East and Africa Risperidone Sales by Type (2017-2028)
10.1.2 Middle East and Africa Risperidone Revenue by Type (2017-2028)
10.2 Middle East and Africa Risperidone Market Size by Application
10.2.1 Middle East and Africa Risperidone Sales by Application (2017-2028)
10.2.2 Middle East and Africa Risperidone Revenue by Application (2017-2028)
10.3 Middle East and Africa Risperidone Market Size by Country
10.3.1 Middle East and Africa Risperidone Sales by Country (2017-2028)
10.3.2 Middle East and Africa Risperidone Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Janssen Pharmaceutica
11.1.1 Janssen Pharmaceutica Corporation Information
11.1.2 Janssen Pharmaceutica Overview
11.1.3 Janssen Pharmaceutica Risperidone Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Janssen Pharmaceutica Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Janssen Pharmaceutica Recent Developments
11.2 Teva
11.2.1 Teva Corporation Information
11.2.2 Teva Overview
11.2.3 Teva Risperidone Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Teva Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Teva Recent Developments
11.3 Sun Pharmaceutical
11.3.1 Sun Pharmaceutical Corporation Information
11.3.2 Sun Pharmaceutical Overview
11.3.3 Sun Pharmaceutical Risperidone Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Sun Pharmaceutical Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Sun Pharmaceutical Recent Developments
11.4 Aurobindo
11.4.1 Aurobindo Corporation Information
11.4.2 Aurobindo Overview
11.4.3 Aurobindo Risperidone Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Aurobindo Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Aurobindo Recent Developments
11.5 Cipla
11.5.1 Cipla Corporation Information
11.5.2 Cipla Overview
11.5.3 Cipla Risperidone Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Cipla Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Cipla Recent Developments
11.6 Invent Farma Group
11.6.1 Invent Farma Group Corporation Information
11.6.2 Invent Farma Group Overview
11.6.3 Invent Farma Group Risperidone Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Invent Farma Group Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Invent Farma Group Recent Developments
11.7 Medichem
11.7.1 Medichem Corporation Information
11.7.2 Medichem Overview
11.7.3 Medichem Risperidone Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Medichem Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Medichem Recent Developments
11.8 Interquim
11.8.1 Interquim Corporation Information
11.8.2 Interquim Overview
11.8.3 Interquim Risperidone Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Interquim Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Interquim Recent Developments
11.9 IPCA
11.9.1 IPCA Corporation Information
11.9.2 IPCA Overview
11.9.3 IPCA Risperidone Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 IPCA Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 IPCA Recent Developments
11.10 RPG
11.10.1 RPG Corporation Information
11.10.2 RPG Overview
11.10.3 RPG Risperidone Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 RPG Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 RPG Recent Developments
11.11 Sharon
11.11.1 Sharon Corporation Information
11.11.2 Sharon Overview
11.11.3 Sharon Risperidone Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Sharon Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Sharon Recent Developments
11.12 Torrent Pharmaceuticals
11.12.1 Torrent Pharmaceuticals Corporation Information
11.12.2 Torrent Pharmaceuticals Overview
11.12.3 Torrent Pharmaceuticals Risperidone Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Torrent Pharmaceuticals Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Torrent Pharmaceuticals Recent Developments
11.13 Temad
11.13.1 Temad Corporation Information
11.13.2 Temad Overview
11.13.3 Temad Risperidone Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Temad Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Temad Recent Developments
11.14 Wuxi Jida
11.14.1 Wuxi Jida Corporation Information
11.14.2 Wuxi Jida Overview
11.14.3 Wuxi Jida Risperidone Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Wuxi Jida Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Wuxi Jida Recent Developments
11.15 Changzhou Siyao Pharmaceuticals
11.15.1 Changzhou Siyao Pharmaceuticals Corporation Information
11.15.2 Changzhou Siyao Pharmaceuticals Overview
11.15.3 Changzhou Siyao Pharmaceuticals Risperidone Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Changzhou Siyao Pharmaceuticals Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Changzhou Siyao Pharmaceuticals Recent Developments
11.16 Ningbo Team Pharm
11.16.1 Ningbo Team Pharm Corporation Information
11.16.2 Ningbo Team Pharm Overview
11.16.3 Ningbo Team Pharm Risperidone Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Ningbo Team Pharm Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Ningbo Team Pharm Recent Developments
11.17 Zhejiang Huahai Pharmaceutical
11.17.1 Zhejiang Huahai Pharmaceutical Corporation Information
11.17.2 Zhejiang Huahai Pharmaceutical Overview
11.17.3 Zhejiang Huahai Pharmaceutical Risperidone Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 Zhejiang Huahai Pharmaceutical Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Zhejiang Huahai Pharmaceutical Recent Developments
11.18 TIPR
11.18.1 TIPR Corporation Information
11.18.2 TIPR Overview
11.18.3 TIPR Risperidone Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 TIPR Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 TIPR Recent Developments
11.19 Qilu Pharmaceutical
11.19.1 Qilu Pharmaceutical Corporation Information
11.19.2 Qilu Pharmaceutical Overview
11.19.3 Qilu Pharmaceutical Risperidone Sales, Price, Revenue and Gross Margin (2017-2022)
11.19.4 Qilu Pharmaceutical Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Qilu Pharmaceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Risperidone Industry Chain Analysis
12.2 Risperidone Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Risperidone Production Mode & Process
12.4 Risperidone Sales and Marketing
12.4.1 Risperidone Sales Channels
12.4.2 Risperidone Distributors
12.5 Risperidone Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Risperidone Industry Trends
13.2 Risperidone Market Drivers
13.3 Risperidone Market Challenges
13.4 Risperidone Market Restraints
14 Key Findings in The Global Risperidone Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Risperidone Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Oral
Table 3. Major Manufacturers of Injectable
Table 4. Global Risperidone Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Risperidone Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Risperidone Sales by Region (2017-2022) & (K Pcs)
Table 7. Global Risperidone Sales Market Share by Region (2017-2022)
Table 8. Global Risperidone Sales by Region (2023-2028) & (K Pcs)
Table 9. Global Risperidone Sales Market Share by Region (2023-2028)
Table 10. Global Risperidone Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Risperidone Revenue Market Share by Region (2017-2022)
Table 12. Global Risperidone Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Risperidone Revenue Market Share by Region (2023-2028)
Table 14. Global Risperidone Sales by Manufacturers (2017-2022) & (K Pcs)
Table 15. Global Risperidone Sales Share by Manufacturers (2017-2022)
Table 16. Global Risperidone Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Risperidone Revenue Share by Manufacturers (2017-2022)
Table 18. Risperidone Price by Manufacturers (2017-2022) &(USD/Pcs)
Table 19. Global Risperidone Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Risperidone by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Risperidone as of 2021)
Table 21. Risperidone Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Risperidone Product Offered
Table 23. Date of Manufacturers Enter into Risperidone Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Risperidone Sales by Type (2017-2022) & (K Pcs)
Table 26. Global Risperidone Sales by Type (2023-2028) & (K Pcs)
Table 27. Global Risperidone Sales Share by Type (2017-2022)
Table 28. Global Risperidone Sales Share by Type (2023-2028)
Table 29. Global Risperidone Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Risperidone Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Risperidone Revenue Share by Type (2017-2022)
Table 32. Global Risperidone Revenue Share by Type (2023-2028)
Table 33. Risperidone Price by Type (2017-2022) & (USD/Pcs)
Table 34. Global Risperidone Price Forecast by Type (2023-2028) & (USD/Pcs)
Table 35. Global Risperidone Sales by Application (2017-2022) & (K Pcs)
Table 36. Global Risperidone Sales by Application (2023-2028) & (K Pcs)
Table 37. Global Risperidone Sales Share by Application (2017-2022)
Table 38. Global Risperidone Sales Share by Application (2023-2028)
Table 39. Global Risperidone Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Risperidone Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Risperidone Revenue Share by Application (2017-2022)
Table 42. Global Risperidone Revenue Share by Application (2023-2028)
Table 43. Risperidone Price by Application (2017-2022) & (USD/Pcs)
Table 44. Global Risperidone Price Forecast by Application (2023-2028) & (USD/Pcs)
Table 45. North America Risperidone Sales by Type (2017-2022) & (K Pcs)
Table 46. North America Risperidone Sales by Type (2023-2028) & (K Pcs)
Table 47. North America Risperidone Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Risperidone Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Risperidone Sales by Application (2017-2022) & (K Pcs)
Table 50. North America Risperidone Sales by Application (2023-2028) & (K Pcs)
Table 51. North America Risperidone Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Risperidone Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Risperidone Sales by Country (2017-2022) & (K Pcs)
Table 54. North America Risperidone Sales by Country (2023-2028) & (K Pcs)
Table 55. North America Risperidone Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Risperidone Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Risperidone Sales by Type (2017-2022) & (K Pcs)
Table 58. Europe Risperidone Sales by Type (2023-2028) & (K Pcs)
Table 59. Europe Risperidone Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Risperidone Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Risperidone Sales by Application (2017-2022) & (K Pcs)
Table 62. Europe Risperidone Sales by Application (2023-2028) & (K Pcs)
Table 63. Europe Risperidone Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Risperidone Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Risperidone Sales by Country (2017-2022) & (K Pcs)
Table 66. Europe Risperidone Sales by Country (2023-2028) & (K Pcs)
Table 67. Europe Risperidone Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Risperidone Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Risperidone Sales by Type (2017-2022) & (K Pcs)
Table 70. Asia Pacific Risperidone Sales by Type (2023-2028) & (K Pcs)
Table 71. Asia Pacific Risperidone Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Risperidone Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Risperidone Sales by Application (2017-2022) & (K Pcs)
Table 74. Asia Pacific Risperidone Sales by Application (2023-2028) & (K Pcs)
Table 75. Asia Pacific Risperidone Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Risperidone Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Risperidone Sales by Region (2017-2022) & (K Pcs)
Table 78. Asia Pacific Risperidone Sales by Region (2023-2028) & (K Pcs)
Table 79. Asia Pacific Risperidone Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Risperidone Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Risperidone Sales by Type (2017-2022) & (K Pcs)
Table 82. Latin America Risperidone Sales by Type (2023-2028) & (K Pcs)
Table 83. Latin America Risperidone Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Risperidone Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Risperidone Sales by Application (2017-2022) & (K Pcs)
Table 86. Latin America Risperidone Sales by Application (2023-2028) & (K Pcs)
Table 87. Latin America Risperidone Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Risperidone Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Risperidone Sales by Country (2017-2022) & (K Pcs)
Table 90. Latin America Risperidone Sales by Country (2023-2028) & (K Pcs)
Table 91. Latin America Risperidone Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Risperidone Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Risperidone Sales by Type (2017-2022) & (K Pcs)
Table 94. Middle East and Africa Risperidone Sales by Type (2023-2028) & (K Pcs)
Table 95. Middle East and Africa Risperidone Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Risperidone Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Risperidone Sales by Application (2017-2022) & (K Pcs)
Table 98. Middle East and Africa Risperidone Sales by Application (2023-2028) & (K Pcs)
Table 99. Middle East and Africa Risperidone Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Risperidone Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Risperidone Sales by Country (2017-2022) & (K Pcs)
Table 102. Middle East and Africa Risperidone Sales by Country (2023-2028) & (K Pcs)
Table 103. Middle East and Africa Risperidone Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Risperidone Revenue by Country (2023-2028) & (US$ Million)
Table 105. Janssen Pharmaceutica Corporation Information
Table 106. Janssen Pharmaceutica Description and Major Businesses
Table 107. Janssen Pharmaceutica Risperidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 108. Janssen Pharmaceutica Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Janssen Pharmaceutica Recent Developments
Table 110. Teva Corporation Information
Table 111. Teva Description and Major Businesses
Table 112. Teva Risperidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 113. Teva Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Teva Recent Developments
Table 115. Sun Pharmaceutical Corporation Information
Table 116. Sun Pharmaceutical Description and Major Businesses
Table 117. Sun Pharmaceutical Risperidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 118. Sun Pharmaceutical Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Sun Pharmaceutical Recent Developments
Table 120. Aurobindo Corporation Information
Table 121. Aurobindo Description and Major Businesses
Table 122. Aurobindo Risperidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 123. Aurobindo Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Aurobindo Recent Developments
Table 125. Cipla Corporation Information
Table 126. Cipla Description and Major Businesses
Table 127. Cipla Risperidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 128. Cipla Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Cipla Recent Developments
Table 130. Invent Farma Group Corporation Information
Table 131. Invent Farma Group Description and Major Businesses
Table 132. Invent Farma Group Risperidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 133. Invent Farma Group Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Invent Farma Group Recent Developments
Table 135. Medichem Corporation Information
Table 136. Medichem Description and Major Businesses
Table 137. Medichem Risperidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 138. Medichem Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Medichem Recent Developments
Table 140. Interquim Corporation Information
Table 141. Interquim Description and Major Businesses
Table 142. Interquim Risperidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 143. Interquim Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Interquim Recent Developments
Table 145. IPCA Corporation Information
Table 146. IPCA Description and Major Businesses
Table 147. IPCA Risperidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 148. IPCA Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. IPCA Recent Developments
Table 150. RPG Corporation Information
Table 151. RPG Description and Major Businesses
Table 152. RPG Risperidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 153. RPG Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. RPG Recent Developments
Table 155. Sharon Corporation Information
Table 156. Sharon Description and Major Businesses
Table 157. Sharon Risperidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 158. Sharon Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. Sharon Recent Developments
Table 160. Torrent Pharmaceuticals Corporation Information
Table 161. Torrent Pharmaceuticals Description and Major Businesses
Table 162. Torrent Pharmaceuticals Risperidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 163. Torrent Pharmaceuticals Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
Table 164. Torrent Pharmaceuticals Recent Developments
Table 165. Temad Corporation Information
Table 166. Temad Description and Major Businesses
Table 167. Temad Risperidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 168. Temad Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
Table 169. Temad Recent Developments
Table 170. Wuxi Jida Corporation Information
Table 171. Wuxi Jida Description and Major Businesses
Table 172. Wuxi Jida Risperidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 173. Wuxi Jida Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
Table 174. Wuxi Jida Recent Developments
Table 175. Changzhou Siyao Pharmaceuticals Corporation Information
Table 176. Changzhou Siyao Pharmaceuticals Description and Major Businesses
Table 177. Changzhou Siyao Pharmaceuticals Risperidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 178. Changzhou Siyao Pharmaceuticals Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
Table 179. Changzhou Siyao Pharmaceuticals Recent Developments
Table 180. Ningbo Team Pharm Corporation Information
Table 181. Ningbo Team Pharm Description and Major Businesses
Table 182. Ningbo Team Pharm Risperidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 183. Ningbo Team Pharm Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
Table 184. Ningbo Team Pharm Recent Developments
Table 185. Zhejiang Huahai Pharmaceutical Corporation Information
Table 186. Zhejiang Huahai Pharmaceutical Description and Major Businesses
Table 187. Zhejiang Huahai Pharmaceutical Risperidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 188. Zhejiang Huahai Pharmaceutical Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
Table 189. Zhejiang Huahai Pharmaceutical Recent Developments
Table 190. TIPR Corporation Information
Table 191. TIPR Description and Major Businesses
Table 192. TIPR Risperidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 193. TIPR Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
Table 194. TIPR Recent Developments
Table 195. Qilu Pharmaceutical Corporation Information
Table 196. Qilu Pharmaceutical Description and Major Businesses
Table 197. Qilu Pharmaceutical Risperidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 198. Qilu Pharmaceutical Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
Table 199. Qilu Pharmaceutical Recent Developments
Table 200. Key Raw Materials Lists
Table 201. Raw Materials Key Suppliers Lists
Table 202. Risperidone Distributors List
Table 203. Risperidone Customers List
Table 204. Risperidone Market Trends
Table 205. Risperidone Market Drivers
Table 206. Risperidone Market Challenges
Table 207. Risperidone Market Restraints
Table 208. Research Programs/Design for This Report
Table 209. Key Data Information from Secondary Sources
Table 210. Key Data Information from Primary Sources
List of Figures
Figure 1. Risperidone Product Picture
Figure 3. Global Risperidone Market Share by Type in 2021 & 2028
Figure 3. Oral Product Picture
Figure 4. Injectable Product Picture
Figure 5. Global Risperidone Market Share by Application in 2021 & 2028
Figure 6. Schizophrenia
Figure 7. Bipolar Disorder
Figure 8. Risperidone Report Years Considered
Figure 9. Global Risperidone Sales 2017-2028 (K Pcs)
Figure 10. Global Risperidone Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Risperidone Revenue 2017-2028 (US$ Million)
Figure 12. Global Risperidone Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 13. Global Risperidone Sales Market Share by Region (2017-2022)
Figure 14. Global Risperidone Sales Market Share by Region (2023-2028)
Figure 15. North America Risperidone Sales YoY (2017-2028) & (K Pcs)
Figure 16. North America Risperidone Revenue YoY (2017-2028) & (US$ Million)
Figure 17. Europe Risperidone Sales YoY (2017-2028) & (K Pcs)
Figure 18. Europe Risperidone Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Asia-Pacific Risperidone Sales YoY (2017-2028) & (K Pcs)
Figure 20. Asia-Pacific Risperidone Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Latin America Risperidone Sales YoY (2017-2028) & (K Pcs)
Figure 22. Latin America Risperidone Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Middle East & Africa Risperidone Sales YoY (2017-2028) & (K Pcs)
Figure 24. Middle East & Africa Risperidone Revenue YoY (2017-2028) & (US$ Million)
Figure 25. The Risperidone Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 26. The Top 5 and 10 Largest Manufacturers of Risperidone in the World: Market Share by Risperidone Revenue in 2021
Figure 27. Global Risperidone Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 28. Global Risperidone Sales Market Share by Type (2017-2028)
Figure 29. Global Risperidone Revenue Market Share by Type (2017-2028)
Figure 30. Global Risperidone Sales Market Share by Application (2017-2028)
Figure 31. Global Risperidone Revenue Market Share by Application (2017-2028)
Figure 32. North America Risperidone Sales Market Share by Type (2017-2028)
Figure 33. North America Risperidone Revenue Market Share by Type (2017-2028)
Figure 34. North America Risperidone Sales Market Share by Application (2017-2028)
Figure 35. North America Risperidone Revenue Market Share by Application (2017-2028)
Figure 36. North America Risperidone Sales Share by Country (2017-2028)
Figure 37. North America Risperidone Revenue Share by Country (2017-2028)
Figure 38. U.S. Risperidone Revenue (2017-2028) & (US$ Million)
Figure 39. Canada Risperidone Revenue (2017-2028) & (US$ Million)
Figure 40. Europe Risperidone Sales Market Share by Type (2017-2028)
Figure 41. Europe Risperidone Revenue Market Share by Type (2017-2028)
Figure 42. Europe Risperidone Sales Market Share by Application (2017-2028)
Figure 43. Europe Risperidone Revenue Market Share by Application (2017-2028)
Figure 44. Europe Risperidone Sales Share by Country (2017-2028)
Figure 45. Europe Risperidone Revenue Share by Country (2017-2028)
Figure 46. Germany Risperidone Revenue (2017-2028) & (US$ Million)
Figure 47. France Risperidone Revenue (2017-2028) & (US$ Million)
Figure 48. U.K. Risperidone Revenue (2017-2028) & (US$ Million)
Figure 49. Italy Risperidone Revenue (2017-2028) & (US$ Million)
Figure 50. Russia Risperidone Revenue (2017-2028) & (US$ Million)
Figure 51. Asia Pacific Risperidone Sales Market Share by Type (2017-2028)
Figure 52. Asia Pacific Risperidone Revenue Market Share by Type (2017-2028)
Figure 53. Asia Pacific Risperidone Sales Market Share by Application (2017-2028)
Figure 54. Asia Pacific Risperidone Revenue Market Share by Application (2017-2028)
Figure 55. Asia Pacific Risperidone Sales Share by Region (2017-2028)
Figure 56. Asia Pacific Risperidone Revenue Share by Region (2017-2028)
Figure 57. China Risperidone Revenue (2017-2028) & (US$ Million)
Figure 58. Japan Risperidone Revenue (2017-2028) & (US$ Million)
Figure 59. South Korea Risperidone Revenue (2017-2028) & (US$ Million)
Figure 60. India Risperidone Revenue (2017-2028) & (US$ Million)
Figure 61. Australia Risperidone Revenue (2017-2028) & (US$ Million)
Figure 62. China Taiwan Risperidone Revenue (2017-2028) & (US$ Million)
Figure 63. Indonesia Risperidone Revenue (2017-2028) & (US$ Million)
Figure 64. Thailand Risperidone Revenue (2017-2028) & (US$ Million)
Figure 65. Malaysia Risperidone Revenue (2017-2028) & (US$ Million)
Figure 66. Latin America Risperidone Sales Market Share by Type (2017-2028)
Figure 67. Latin America Risperidone Revenue Market Share by Type (2017-2028)
Figure 68. Latin America Risperidone Sales Market Share by Application (2017-2028)
Figure 69. Latin America Risperidone Revenue Market Share by Application (2017-2028)
Figure 70. Latin America Risperidone Sales Share by Country (2017-2028)
Figure 71. Latin America Risperidone Revenue Share by Country (2017-2028)
Figure 72. Mexico Risperidone Revenue (2017-2028) & (US$ Million)
Figure 73. Brazil Risperidone Revenue (2017-2028) & (US$ Million)
Figure 74. Argentina Risperidone Revenue (2017-2028) & (US$ Million)
Figure 75. Middle East and Africa Risperidone Sales Market Share by Type (2017-2028)
Figure 76. Middle East and Africa Risperidone Revenue Market Share by Type (2017-2028)
Figure 77. Middle East and Africa Risperidone Sales Market Share by Application (2017-2028)
Figure 78. Middle East and Africa Risperidone Revenue Market Share by Application (2017-2028)
Figure 79. Middle East and Africa Risperidone Sales Share by Country (2017-2028)
Figure 80. Middle East and Africa Risperidone Revenue Share by Country (2017-2028)
Figure 81. Turkey Risperidone Revenue (2017-2028) & (US$ Million)
Figure 82. Saudi Arabia Risperidone Revenue (2017-2028) & (US$ Million)
Figure 83. UAE Risperidone Revenue (2017-2028) & (US$ Million)
Figure 84. Risperidone Value Chain
Figure 85. Risperidone Production Process
Figure 86. Channels of Distribution
Figure 87. Distributors Profiles
Figure 88. Bottom-up and Top-down Approaches for This Report
Figure 89. Data Triangulation
Figure 90. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Janssen Pharmaceutica Teva Sun Pharmaceutical Aurobindo Cipla Invent Farma Group Medichem Interquim IPCA RPG Sharon Torrent Pharmaceuticals Temad Wuxi Jida Changzhou Siyao Pharmaceuticals Ningbo Team Pharm Zhejiang Huahai Pharmaceutical TIPR Qilu Pharmaceutical